Trial
NCT02145676
OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Allergan
Collaborators
—
Condition
Muscle Spasticity
Intervention
onabotulinumtoxinA
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-12